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Abstract
Background: Hearing loss is a clinically and genetically heterogeneous disorder. Mutations in the DFNB1 locus
have been reported to be the most common cause of autosomal recessive non-syndromic hearing loss worldwide.
Apart from DFNB1, many other loci and their underlying genes have also been identified and the basis of our
study was to provide a comprehensive introduction to the delineation of the molecular basis of non-syndromic
hearing loss in the Saudi Arabian population. This was performed by screening DFNB1 and to initiate prioritized
linkage analysis or homozygosity mapping for a pilot number of families in which DFNB1 has been excluded.
Methods: Individuals from 130 families of Saudi Arabian tribal origin diagnosed with an autosomal recessive non-
syndromic sensorineural hearing loss were screened for mutations at the DFNB1 locus by direct sequencing. If
negative, genome wide linkage analysis or homozygosity mapping were performed using Affymetrix GeneChip
®
Human Mapping 250K/6.0 Arrays to identify regions containing any known-deafness causing genes that were
subsequently sequenced.
Results: Our results strongly indicate that DFNB1 only accounts for 3% of non-syndromic hearing loss in the Saudi
Arabian population of ethnic ancestry. Prioritized linkage analysis or homozygosity mapping in five separate
families established that their hearing loss was caused by five different known-deafness causing genes thus
confirming the genetic heterogeneity of this disorder in the kingdom.
Conclusion: The overall results of this study are highly suggestive that underlying molecular basis of autosomal
recessive non-syndromic deafness in Saudi Arabia is very genetically heterogeneous. In addition, we report that the
preliminary results indicate that there does not seem to be any common or more prevalent loci, genes or
mutations in patients with autosomal recessive non-syndromic hearing loss in patients of Saudi Arabian tribal
origin.
Background
Deafness, the inability to hear, is the most common sen-
sory deficit in human populations with both genetic and
environmental etiologies. It is estimated that it affects 1
in 1000 child births of which approximately 60% cases
are attributed to genetic factors [1]. Hearing impairment
is clinically and genetically heterogeneous. Impaired
auditory function can be the only clinical manifestation
(non-syndromic forms of deafness) or can be associated
with other symptoms or anomalies (syndromic forms of
deafness). It has been estimated that at least 300 human
protein-coding genes are involved in the hearing process
[2]. During the last decade, many deafness loci and the
underlying genes have been identified at a rapid rate.
T h em a i np a t t e r no fi n h e r i t a n c ei ns e v e r ec h i l d h o o d
deafness is autosomal recessive (over 75%) while autoso-
mal dominant (12-24%), X-linked (1-3%) and mitochon-
drial is also involved [3]. In general, recessive deafness is
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because it is generally profound, prelingual and fully
penetrant whereas dominant deafness is often progres-
sive, post lingual and is frequently observed clinically as
unilateral or mild bilateral deafness [4]. In addition,
recessively inherited diseases are more prevalent in
populations where consanguineous marriages are com-
mon, like in the kingdom of Saudi Arabia. The same
effect is observed for recessively inherited cases of
deafness.
Autosomal recessive non-syndromic hearing loss
(ARNSHL) is the most frequent cause of hereditary deaf-
ness and often exhibits the most severe hearing phenotype.
Presently, 85 recessive deafness (DFNB) loci have been
registered and 35 of the corresponding genes have been
identified as documented on the Hereditary Hearing Loss
Homepage http://hereditaryhearingloss.org. Interestingly,
even though a substantial number of genes are known to
cause ARNSHL, mutations at the first identified DFNB1
locus, account for up to 50% of all cases with this diagno-
sis in various populations. DFNB1 contains the GJB2 and
GJB6 genes that respectively code for connexin 26 (C×26)
and connexin 30 (C×30), which are gap junction binding
proteins, most abundantly expressed in the cochlea.
Although over 100 mutations have been reported in GJB2
(The Connexin-deafness homepage: http://davinci.crg.es/
d e a f n e s s ) ,as i n g l em u t a t i o n, c.35delG, is the most com-
mon cause of ARNSHL and can account for up to 85% of
DFNB1 in various populations [5]. DFNB1 also harbors
the second most common ARNSHL causing mutation, a
309 kb deletion of GJB6, often found in trans with muta-
tions in GJB2, giving rise to a digenic inheritance of this
form of hereditary hearing loss.
In view of the extensive studies conducted worldwide,
the major objective of this study was to begin to compre-
hensively delineate the genetic basis of ARNSHL in indivi-
duals of Saudi Arabian origin. To achieve this objective,
individuals segregating with severe to profound, non-
syndromic congenital deafness with an autosomal recessive
mode of inheritance were identified from different cities of
Saudi Arabia and initially screened for mutations encom-
passing the DFNB1 locus.
The second aim was to initiate prioritized linkage ana-
lysis (in families of three or more affected individuals)
and homozygosity mapping (in families with two affected
sib-pair individuals) of other known deafness loci for
families in which DFNB1 has been excluded. This further
bi-directional approach was necessary due to the vast
heterogeneity and complexity of the number of genes
known and unknown causing hereditary deafness. In this
study, using SNP-based genotyping arrays, candidate
genes were selected and screened in the chromosomal
region that generated the highest LOD score (multipoint
linkage analysis) or in the largest region of homozygosity
shared by the affected sib-pairs that was not seen in the
parents or unaffected siblings if applicable. This genome-
wide homozygosity mapping analysis approach was used
in this study in particular, as it assumes that individuals
affected with an autosomal recessive disease, born from
parents of a consanguineous marriage are very likely to
be homozygous for the pathogenic mutation and for a
substantial number of SNPs surrounding it [6].
T h eo v e r a l lr e s u l t so ft h i ss t u d ya r eh i g h l ys u g g e s t i v e
that underlying molecular basis of autosomal recessive
non-syndromic deafness in Saudi Arabia is very geneti-
cally heterogeneous. In addition, we report that from
the results of our pilot study there does not seem to be
any common or more prevalent loci, genes or mutations
in patients with ARNSHL originating from the kingdom.
Methods
Subjects
All of the individuals (patients and family members)
who participated in this study provided an approved
informed consent form, which adhered to institutional
(King Faisal Specialist Hospital; RAC# 2040039) and
international guidelines as outlined by the Declaration
of Helsinki.
Clinical evaluation
Detailed medical histories were obtained for all of the
enrolled affected individuals regarding time and age of
onset of hearing loss (pre-lingual, post-lingual), severity
of hearing loss (mild, moderate or profound) and in
order to exclude syndromic abnormalities, environmental
causes for hearing loss and an autosomal dominant
inheritance pattern of hearing loss. Pure tone audiometry
tests for air and bone conduction were performed on all
affected individuals. Evaluation of vestibular and ocular
function was performed to exclude suspected forms of
syndromic deafness.
Sample Collection and DNA Extraction
Whole blood samples (10 ml) for molecular genetic ana-
lysis were obtained from affected patients, their parents
and unaffected siblings (if available). Genomic extraction
of DNA was performed using the standard salting-out
method [7].
Mutation Detection in GJB2 and GJB6
Mutation screening by direct dideoxy chain-termination
sequencing of the entire coding region of PCR generated
amplicons (using standard PCR conditions) was per-
formed for both the GJB2 and GJB6 genes in all affected
individuals in the study using an ABI Prism Big Dye Ter-
minator v3.1 Cycle Sequencing Kit following the manu-
facturer’s instructions and processed on a MegaBACE
1000 DNA Analysis System (Molecular Dynamics;
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using the SeqMan 6.1 module of the Lasergene (DNA
Star Inc. WI, USA) software package, then compared to
the reference GenBank sequence (accession number:
GJB2; NM_004004 and GJB6; NM_001110219). Number-
ing commenced with the A of the ATG initiation codon
as +1.
Linkage analysis
SNP-based genotyping was performed using the Affyme-
trix GeneChip
® Human Mapping 250 K and 6.0 Arrays
(Affymetrix, Santa Clara, CA, USA) as per the user’s
manual. The genotypes of SNPs were called using Affy-
metrix GCOS 1.4 software, which generated an overall
average SNP call rate of 97% and were further sorted
per chromosome and by physical position. The Allegro
module of the Easy Linkage software package was used
to calculate multipoint logarithm of odds (LOD) scores,
with the parameters that assume a disease model with
an autosomal-recessive mode of inheritance with 100%
penetrance and a disease allele frequency of 0.0001.
The resulting multipoint linkage analysis of the
affected patients, their unaffected siblings, and their par-
ents which resulted in the highest maximum LOD score
was investigated. Any known deafness causing gene(s)
located in this interval were assumed the likely disease-
causing candidate and the patients were screened by
direct sequencing of the coding sequence for the parti-
cular gene(s).
Homozygosity mapping
The resulting SNP-based genotyping data (as in Linkage
Analysis) was analyzed to detect regions of homozygosity
using CNAG 3.0 and GTConsole Version 3.0.1 (Affyme-
trix, Santa Clara, CA, USA) software packages. Conven-
tionally, regions of homozygosity are defined as fragments
where SNPs are homozygous for a stretch of consecutive
alleles in affected individuals and heterozygous or homo-
zygous for the other allele in unaffected members of the
same family. As previously reported by researchers using
this approach [8], it is advantageous to identify and initi-
ally screen candidate genes present in the largest region of
homozygosity shared between affected family members,
however this was not true in all families that were ana-
lyzed in this manner.
Mutation Detection in MYO15A, TMPRSS3, TRIC, LHFPL5,
TMC1
After linkage and homozygosity mapping analysis, geno-
mic DNA from relevant individuals was amplified using
standard PCR conditions with intronic primers that
were designed to flank (50-100 bp) each of coding exons
of MYO15A, TMPRSS3, TRIC, LHFPL5 and TMC1 as
mentioned previously (primer sequences and conditions
are available on request).
RT-PCR
To determine the effect of the novel splice-acceptor site
mutation (IVS12-1 g>c) in family KT1 with respect to
mRNA splicing, a fragment comprising exon 11 and 12 of
TMPRSS3 was amplified using RT-PCR with mRNA iso-
lated from peripheral blood lymphocytes. Preparation of
the cDNA was carried out using the iScript™ cDNA
synthesis kit and random primers (Applied Biosystems,
Carlsbad, CA). One microgram of total RNA from the
patient and a normal control was reverse transcribed
using an aliquot of a reverse transcription reaction con-
taining 1 × PCR buffer, 2.5 mM MgCl2, 0.2 mM of each
dNTP, and 0.5 U AMV reverse transcriptase (Roche Diag-
nostics GmbH, Mannheim, Germany). 10 μl of cDNA was
amplified by PCR using the 5’ primer (TCC AAC AAG
ATC TGC AAC CA) and the 3’ primer (ATC CAG TCC
AGG AAG GAG GT) using standard conditions. PCR
products were then evaluated on 2% agarose gel and were
purified using the QIAquick PCR Purification Kit accord-
ing to the manufacturer’s instructions (Qiagen, German-
town, MD) and then sequenced as described above.
Results
GJB2 and GJB6 were screened from affected individuals
with pre-lingual severe to profound ARNSHL from a
total of 130 families, which included both multiple
affected and sporadic cases. DFNB1 mutations were iden-
tified in only 4 of the 130 families. Patients from two of
the families were homoallelic for the common c.35delG
mutation in GJB2. One patient was homozygous for the
R32H mutation and the fourth patient was homozygous
for W77R, both of which have been previously reported
in GJB2 (Table 1). No other mutations have been found
in GJB2 or GJB6 (including the 309-kb deletion) in this
largest cohort of patients from this population. There-
fore, our results show that mutations in DFNB1 account
for only 3% of ARNSHL in patients of Saudi Arabian tri-
bal ethnicity.
Linkage analysis and homozygosity mapping in 5
Families with ARNSHL
The exclusion of DFNB1 as a major cause of ARNSHL
allowed us to accelerate our efforts with respect to link-
age analysis and homozygosity mapping. 70 of the 130
families that were enrolled in the study had 2 or more
affected individuals, the remaining being made up of
sporadic cases. Initially as a pilot study, patients from five
families were selected for analysis on the basis that the
parents confirmed consanguineous marriages and that
the non-syndromic hearing loss was consistent with a
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individuals were subjected to LOD score calculation by
linkage analysis and the remaining 3 families with two
affected individuals were analyzed by homozygosity map-
ping (Figure 1). Multipoint linkage analysis of the first
family generated a LOD score of 2.5 on chromosome
17p12-p11.2 in which MYO15A was selected as a candi-
date within a 6.0 Mb linkage interval. Similar analysis on
the second family resulted in a maximum LOD score of
2.7 (Figure 1) and identified a disease locus on
chromosome 21q22.3, which spanned approximately
1.5 Mb. TMPRSS3 was selected as a potential candidate
in this region. Homozygosity mapping analysis in the
remaining 3 sibships generated multiple regions of
homozygosity that was shared only among affected indi-
viduals. But as previously discussed, any known DFNB
genes that were located in the longest stretch of homo-
zygosity were chosen for sequencing in the respective
family. On this basis, TRIC, LHFPL5,a n dTMC1 were
selected to be directly sequenced from the genomic DNA
Table 1 Summary of mutations in various known deafness genes identified in ARNSHL patients from Saudi Arabia
FAMILY/
SIBSHIPS
MODE OF ANALYSIS REGION OF
INTEREST
GENE OF
INTEREST
NUCLEOTIDE
CHANGE
PROTEIN
CHANGE
REFERENCE
NSHD28/69 DFNB1 SCREENING NA GJB2 c.35delG Frameshift [10]
NSHD74 DFNB1 SCREENING NA GJB2 95 G>A p.R32H [11]
KT7 DFNB1 SCREENING NA GJB2 c.229T>C p.W77R [12]
SS16 Linkage
(LOD SCORE)
Chr 17p12-q11.2 MYO15A c.1047C>A p.Y349X This study
KT1 Linkage
(LOD SCORE)
Chr 21q22.2-q22.3 TMPRSS3 IVS12-1 g>c Splicing error This study
TA12 Homozygosity (GT
console)
Chr 5q11.2-q13.3 TRIC c.1498C>T p.R500X [13]
SS3 Homozygosity (GT
console)
Chr 6p24.3-p12.3 LHFPL5 c.1A>G p.M1V [8]
SS17 Homozygosity (CNAG) Chr 9p13.3-q21.13 TMC1 c.100C>T p.R34X [14]
Figure 1 Family pedigrees, linkage analysis/homozygosity mapping, and mutation data. A) Pedigrees of five Saudi families segregating
with autosomal recessive prelingual profound hearing loss. B) Linkage analysis showing LOD scores of 3.3 on chromosome 17 and 2.7 on
chromosome 21 for families SS16 and KT1, indicating linkage to MYO15A and TMPRSS3 genes, respectively. Homozygosity mapping with GT
console is shown for TRIC and LHFPL5 as genes of interest for families TA12 and SS3, respectively. For family SS17, homozygosity mapping with
CNAG shows the region of homozygosity on chromosome 9 where TMC1 resides. C) Sequencing chromatogram of wild type, heterozygous and
mutant alleles of respective deafness genes for a normal control, a carrier and affected member of each of the families.
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patients were homozygous for the interval containing the
applicable gene.
Mutation Screening in MYO15A, TMPRSS3, TRIC, LHFPL5,
TMC1
Direct sequencing in both the forward and reverse direc-
tions of each candidate gene that the respective affected
siblings linked to, revealed the presence of homozygous
mutations in all of the five genes (Figure 1). The muta-
tions segregated with the disease phenotype where
applicable, i.e. parents were heterozygous carriers for the
mutation and unaffected siblings were either heterozy-
gous carriers or wild-type normal. Two of the five muta-
tions found were novel (Table 1). Neither of the novel
mutations were found in 300 ethnically matched normal
controls, which indicated that these variants were not
population-based polymorphisms.
RT-PCR products were utilized to establish the effect
of the novel splice-acceptor site mutation (IVS12-1 g>c)
in the family KT1 with respect to mRNA splicing in
TMPRSS3. Sequencing results provided the evidence
that the patients which are homozygous for a novel
intronic splice-acceptor site mutation shows the activa-
tion of cryptic splice site 8 bp downstream in the exon
12 leading to a frameshift and incorporation of faulty
amino acids and hence confirms that this mutation does
indeed affect normal splicing and had a major deleter-
ious impact on the structure of the TMPRSS3 mRNA
(Figure 2).
Discussion
Our results strongly indicate that DFNB1 only accounts
for 3% of ARNSHL in the Saudi population (Table 1).
This percentage is significantly lower than a recent
s t u d yb yA l - Q a h t a n ie ta l[ 9 ]w h or e p o r t e dt h a tt h e
total mutations in GJB2 account for 15.59% in their
cohort of patients from the western province of Saudi
Arabia. However, this number is most likely elevated
compared to our results as they reported GJB2 mutation
findings on patients of different ethnic origins, which
they also suggest may be a consequence of migration
and settlement in the geographical area of where their
study was conducted. All of the patients in this study
were of Saudi Arabian tribal origin and therefore, we
believe that 3% is a more accurate estimation of the
contribution of DFNB1 in ARNSHL in individuals ethni-
cally originating from the Kingdom.
Three of the five mutations identified by direct
sequencing of known deafness genes in the candidate
regions identified by linkage analysis/homozygosity map-
ping in 5 families in which DFNB1 had been excluded
have been reported previously (Table 1). The novel non-
sense mutation detected in MYO15A in family SS16
results in the premature truncation at amino acid posi-
tion 349 located in the first domain (N-terminal exten-
sion) of the myosin XVa protein, which is normally
comprised of 3530 amino acids. The second novel muta-
tion, a splice-acceptor site disruption (IVS12-1 g>c) in
the TMPRSS3 gene in family KT1 was confirmed by
RT-PCR to cause abnormal splicing by activation of a
cryptic splice site resulting in a frameshift and incor-
poration of faulty amino acids in this serine protease.
Consanguineous families are a powerful resource for
genetic linkage studies of recessively inherited hearing
impairment. So far, family based analyses have proven
that this methodology is successful and the results have
shown that the hearing loss in five separate families was
caused by five different genes (Table 1), thus tentatively
confirming the already well-established finding of
genetic heterogeneity in ARNSHL worldwide is in fact
analogous in the Saudi population. From the combined
approach and data of the current study, it is not possible
to exclude the possibility of more prevalent ARNSHL-
causing genes in this population that have not yet been
identified. However, it is pertinent to highlight that this
Figure 2 Schematic presentation for the genomic localization
and the sequence of splice site mutation. The IVS12-1 g>c
mutation (indicated by an arrow) creates a 5’ cryptic acceptor site
(AG boxed in red) 8 bp downstream in exon 12 instead of a normal
acceptor site (ag boxed in yellow). Sequencing of the mutant
transcript shows that cryptic splice site leads to a frameshift and
incorporation of faulty amino acids as compared to the wild type.
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validated by our future direction once results are
obtained from further similar family-based analyses, in
addition to whole exome/genome sequencing of our
large number of families with a single affected proband
that are not amenable to analysis using the same linkage
and homozygosity mapping methodology detailed in this
preliminary report.
Conclusion
In conclusion, DFNB1 i sav e r ym i n o rc a u s eo f
ARNSHL in individuals of Saudi Arabian tribal origin.
By using the effective bi-directional approach of linkage
analysis and homozygosity mapping that we have
initiated, we will be able to identify the most common
forms of hereditary hearing loss, their incidence and dis-
tribution in the Saudi population. The benefit of this
study will hopefully provide the foundation for knowl-
edge and awareness through screening of carrier status
and genetic counselling, thereby having a major impact
upon early intervention for and prevention of hereditary
hearing loss.
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